CMEA Capital

CMEA Capital caters seed, early, and later stage venture, private equity, and debt financing investments and is based in California.

Business Model:

Revenue: $14.1M

Employees: 2-10

Rankings

Detailed CMEA Capital Information

Geographic Data

CMEA Capital headquarters map

Address: 1 Letterman Dr

City: San Francisco

State: CA

Zip: 94129

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries. CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today&s;s technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.

Contact Phone:
+14153521520

Contact Email:

Announced Date Company Transaction Money Raised
4/2004 Liveops Series B 22M
11/2008 Evolution Robotics Series B 13.9M
8/2000 Syrrx Series A 5.1M
12/2004 Intermolecular Series A 424k
2/2006 AWR Corporation Venture Round 0
11/2006 Alien Technology Venture Round 50M
5/2008 Multigig Series B 12.5M
5/2011 Jobvite Series C 15M
12/2006 Untangle Series A 10.5M
8/2006 TrueDemand Software Series B 8M
4/2015 Cnano Technology Series B 0
10/2014 Jobvite Series D 0
7/2013 Mojo Networks Series D 0
12/2007 Jobvite Series A 7.2M
7/2009 Blekko Series C 11.5M
12/2009 Solaria Debt Financing 0
5/2008 Untangle, Inc. Series B 8M
5/2009 Visiogen Series D 40M
2/2007 Liveops Series C 28M
12/2011 Graffiti Labs Seed Round 1.6M
5/2014 Arcadia Biosciences Series D 0
11/2006 Kalypsys Series C 100M
2/2008 InSound Medical Series E 11M
11/2008 Danotek Motion Technologies Series A 14.5M
10/2009 Foro Energy Venture Round 25M
1/2010 Cnano Technology Series B 7M
9/2009 Jobvite Series B 8.3M
4/2009 Ambrx Series D 10M
6/2008 Ardelyx Series A 26.1M
10/2007 Relypsa Series A 33M
7/2009 Schooner Information Technology Series B 20M
12/2010 Multigig Series C 10M
3/2008 NuScale Power Venture Round 2.6M
4/2012 WorkingPoint Venture Round 188k
8/2011 Ardelyx Series B 30M
1/2007 Telsima Venture Round 50M
5/2014 Sorbent Therapeutics Series D 0
6/2011 Sorbent Therapeutics Series B 0
12/2005 Agility Design Solutions Series B 7M
4/2013 Spitfire Pharma Venture Round 0
12/2009 Danotek Motion Technologies Venture Round 13.2M
9/2010 Sorbent Therapeutics Series B 0
8/2006 Codexis Series D 0
8/2008 Triporati Venture Round 6M
12/2008 Contour Energy Series A 10.8M
4/2012 Bionic Panda Games Venture Round 800k
9/2011 Blekko Venture Round 30M
9/2011 Beautylish Angel Round 1M
1/2006 Perlegen Sciences Series D 0
2/2005 Perlegen Sciences Series D 0
10/2011 Contour Energy Series C 20M
10/2005 Raven Biotechnologies Series D 48.3M
1/2009 Intermolecular Series D 20M
1/2009 Superprotonic Series C 8M
7/2010 Luminate Series B 12M
7/2006 Ambrx Series C 52M
8/2008 Tetraphase Pharmaceuticals Series A 0
8/2008 Schooner Information Technology Series A 15M
12/2005 Telsima Series C 20M
8/2011 Danotek Motion Technologies Series B 15M
9/2007 Netbooks Series A 6.9M
6/2006 Pyxis Technology Series B 9.2M
5/2015 VYNE Therapeutics Series A 14.3M
12/2008 Symwave Series C 10.2M
7/2008 Amitive Series A 10M
3/2007 Phenomix Series C 55M
4/2007 Mojo Networks Series C 0
4/2009 Pyxis Technology Series C 3M
11/2013 MediaSpike Series A 5.2M
2/2012 Luminate Series C 10.7M
3/2014 Neos Therapeutics Series C 15.5M
4/2008 SpikeSource Series C 20M
11/2012 Auspex Pharmaceuticals Series D 0
10/2010 Auspex Pharmaceuticals Series C 12M
6/2010 Baxano Series C 30M
1/2014 Auspex Pharmaceuticals Series E 0
2/2008 TrueDemand Software Series C 2.7M
12/2008 Solyndra Series E 220M
3/2002 Sanera Systems Venture Round 10M
9/2000 Sanera Systems Series A 17.5M
10/2006 Strix Systems Series G 7M
7/2009 Intellikine Series B 51M
7/2007 Cnano Technology Series A 6M
3/2013 RSI (Reel Solar Inc) Seed Round 4M
3/1997 Silicon Spice Series A 3.3M
2/2010 Contour Energy Series B 14.2M
10/2001 Sanera Systems Series B 38.3M
11/2009 Blekko Series C 2.5M
6/2005 Intermolecular Series B 10.1M
9/2006 Intermolecular Series C 27.6M
7/2012 MediaSpike Seed Round -
3/2009 Luminate Series A 5.8M
10/2011 Zaarly Series A 14.2M
6/2010 Tetraphase Pharmaceuticals Series C 0
4/2005 Teros Series D 0
3/2008 Luminus Devices Series E 72M
5/2015 VYNE Therapeutics Series A 0
4/2015 Cnano Technology Series B 0
10/2014 Jobvite Series D 0
5/2014 Sorbent Therapeutics Series D 0
5/2014 Arcadia Biosciences Series D 0
3/2014 Neos Therapeutics Series C 0
1/2014 Auspex Pharmaceuticals Series E 0
11/2013 MediaSpike Series A 0
7/2013 Mojo Networks Series D 0
4/2013 Spitfire Pharma Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research